Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A)
Article in Journal for ImmunoTherapy of Cancer (April 2024)
The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.
Article in Journal for ImmunoTherapy of Cancer (April 2024)
Article in Clinical and Translational Oncology (April 2024)
Article in Cancer Medicine (November 2023)